Prognosis and predictors of site of first metastasis after definitive radiation therapy for non-small cell lung cancer

References

• Komaki R, Scott CB, Byhardt R, Emami B, Asbell SO, Russell AH, et al. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1998;42:263–7.
   PubMed Web of Science ®Google Scholar
• Cox JD, Scott CB, Byhardt RW, Emami B, Russell AH, Fu KK, et al. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials. Int J Radiat Oncol Biol Phys 1999;43:505–9.
   PubMed Web of Science ®Google Scholar
• Komaki R, Allen PK, Wei X, Blumenschein GR, Tang X, Lee JJ, et al. Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2015;92:317–24.
   PubMed Web of Science ®Google Scholar
• Weichselbaum RR, Hellman S. Oligometastases revisited. Nature Rev Clin Oncol 2011;8:378–82.
   PubMed Web of Science ®Google Scholar
• Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009;9:239–52.
   PubMed Web of Science ®Google Scholar
• Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastas Rev 1989;8:98–101.
   PubMed Web of Science ®Google Scholar
• Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, et al. Metastatic patterns in adenocarcinoma. Cancer 2006;106:1624–33.
   PubMed Web of Science ®Google Scholar
• Robnett TJ, Machtay M, Stevenson JP, Algazy KM, Hahn SM. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. J Clin Oncol 2001;19:1344–9.
   PubMed Web of Science ®Google Scholar
• Hu C, Chang EL, Hassenbusch SJ, 3rd, Allen PK, Woo SY, Mahajan A, et al. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis. Cancer 2006;106:1998–2004.
   PubMed Web of Science ®Google Scholar
• Salama JK, Hasselle MD, Chmura SJ, Malik R, Mehta N, Yenice KM, et al. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 2012;118:2962–70.
   PubMed Web of Science ®Google Scholar
• Parlak C, Mertsoylu H, Guler OC, Onal C, Topkan E. Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous solitary brain metastasis: a curative approach. Int J Radiat Oncol Biol Phys 2014;88:885–91.
   PubMed Web of Science ®Google Scholar
• Sheu T, Heymach JV, Swisher SG, Rao G, Weinberg JS, Mehran R, et al. Propensity Score-Matched Analysis of Comprehensive Local Therapy for Oligometastatic Non-Small Cell Lung Cancer That Did Not Progress After Front-Line Chemotherapy. Int J Radiat Oncol Biol Phys 2014;90:850–7.
   PubMed Web of Science ®Google Scholar
• Hess KR, Levin VA. Getting more out of survival data by using the hazard function. Clin Cancer Res 2014;20:1404–9.
   PubMed Web of Science ®Google Scholar
• Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496–509.
   Web of Science ®Google Scholar
• Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141–54.
   Web of Science ®Google Scholar
• Demicheli R, Fornili M, Ambrogi F, Higgins K, Boyd JA, Biganzoli E, et al. Recurrence dynamics for non-small-cell lung cancer: effect of surgery on the development of metastases. J Thorac Oncol 2012;7:723–30.
   PubMed Web of Science ®Google Scholar
• Varlotto JM, Yao AN, DeCamp MM, Ramakrishna S, Recht A, Flickinger J, et al. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival. Int J Radiat Oncol Biol Phys 2015;91:765–73.
   PubMed Web of Science ®Google Scholar
• Varlotto JM, Medford-Davis LN, Recht A, Flickinger JC, Schaefer E, DeCamp MM. Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011;81:353–9.
   PubMed Web of Science ®Google Scholar
• Hung JJ, Jeng WJ, Hsu WH, Chou TY, Huang BS, Wu YC. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer. J Thorac Oncol 2012;7:1115–23.
   PubMed Web of Science ®Google Scholar
• Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol2007;25:4575–80.
   PubMed Web of Science ®Google Scholar
• Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77:1254–62.
   PubMed Web of Science ®Google Scholar
• O'Connell JP, Kris MG, Gralla RJ, Groshen S, Trust A, Fiore JJ, et al. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. J Clin Oncol 1986;4:1604–14.
   PubMed Web of Science ®Google Scholar
• Rubins J, Unger M, Colice GL, American College Of Chest P. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest 2007;132:355S–67S.
   PubMed Web of Science ®Google Scholar
• Mirsadraee S, Oswal D, Alizadeh Y, Caulo A, van Beek E. Jr., The 7th lung cancer TNM classification and staging system: Review of the changes and implications. World J Radiol 2012;4:128–34.
   PubMedGoogle Scholar